ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,786,701 | -28.7% | 112,738 | -26.0% | 0.04% | -61.0% |
| Q2 2023 | $19,330,801 | -37.4% | 152,259 | -36.4% | 0.10% | +51.5% |
| Q1 2023 | $30,898,430 | -21.0% | 239,226 | -19.6% | 0.07% | -24.1% |
| Q4 2022 | $39,087,528 | +43.7% | 297,719 | +28.0% | 0.09% | +22.5% |
| Q3 2022 | $27,206,000 | +4.0% | 232,610 | +4.6% | 0.07% | +6.0% |
| Q2 2022 | $26,152,000 | -7.2% | 222,322 | +2.8% | 0.07% | +9.8% |
| Q1 2022 | $28,170,000 | -31.1% | 216,193 | -19.3% | 0.06% | -30.7% |
| Q4 2021 | $40,905,000 | +1.3% | 268,017 | +7.3% | 0.09% | -11.1% |
| Q3 2021 | $40,371,000 | +8.5% | 249,697 | +9.9% | 0.10% | +3.1% |
| Q2 2021 | $37,194,000 | +24.1% | 227,279 | +14.2% | 0.10% | -1.0% |
| Q1 2021 | $29,975,000 | -20.5% | 199,092 | -20.0% | 0.10% | -20.5% |
| Q4 2020 | $37,712,000 | -0.5% | 248,941 | -11.0% | 0.12% | -17.6% |
| Q3 2020 | $37,895,000 | +3.2% | 279,852 | +4.2% | 0.15% | -11.4% |
| Q2 2020 | $36,709,000 | +36.9% | 268,559 | +7.9% | 0.17% | +9.9% |
| Q1 2020 | $26,820,000 | +17.8% | 248,929 | +31.7% | 0.15% | +47.6% |
| Q4 2019 | $22,774,000 | +27.2% | 188,984 | +5.0% | 0.10% | +10.8% |
| Q3 2019 | $17,908,000 | -13.5% | 179,985 | -5.1% | 0.09% | -17.7% |
| Q2 2019 | $20,702,000 | -10.0% | 189,751 | -7.7% | 0.11% | -5.8% |
| Q1 2019 | $22,995,000 | -9.1% | 205,678 | -21.6% | 0.12% | -22.1% |
| Q4 2018 | $25,288,000 | -14.4% | 262,238 | +8.2% | 0.15% | +6.9% |
| Q3 2018 | $29,548,000 | +13.6% | 242,318 | +2.3% | 0.14% | -1.4% |
| Q2 2018 | $26,012,000 | -19.7% | 236,861 | -22.0% | 0.15% | -33.3% |
| Q1 2018 | $32,404,000 | +40.7% | 303,576 | +40.8% | 0.22% | +44.1% |
| Q4 2017 | $23,026,000 | -0.3% | 215,663 | +211.4% | 0.15% | -8.4% |
| Q3 2017 | $23,101,000 | +18.2% | 69,249 | +9.9% | 0.17% | +12.2% |
| Q2 2017 | $19,543,000 | +9206.2% | 63,027 | +8715.0% | 0.15% | +7300.0% |
| Q1 2017 | $210,000 | -98.3% | 715 | -98.5% | 0.00% | -98.2% |
| Q4 2016 | $12,484,000 | -10.5% | 47,045 | -2.4% | 0.11% | -16.2% |
| Q3 2016 | $13,956,000 | +86.7% | 48,215 | +66.0% | 0.13% | +78.1% |
| Q2 2016 | $7,475,000 | +7.2% | 29,044 | +8.7% | 0.07% | +9.0% |
| Q1 2016 | $6,971,000 | -42.9% | 26,723 | -25.9% | 0.07% | -46.4% |
| Q4 2015 | $12,199,000 | +38.1% | 36,056 | +23.8% | 0.12% | +12.6% |
| Q3 2015 | $8,834,000 | -21.3% | 29,125 | -4.2% | 0.11% | -14.0% |
| Q2 2015 | $11,223,000 | +12.4% | 30,416 | +4.6% | 0.13% | +13.2% |
| Q1 2015 | $9,988,000 | +9.7% | 29,084 | -3.1% | 0.11% | +4.6% |
| Q4 2014 | $9,105,000 | +8.9% | 30,014 | -1.8% | 0.11% | +0.9% |
| Q3 2014 | $8,362,000 | +15.5% | 30,561 | +8.5% | 0.11% | -11.5% |
| Q2 2014 | $7,238,000 | +21.1% | 28,160 | +11.4% | 0.12% | +11.9% |
| Q1 2014 | $5,976,000 | +16.7% | 25,280 | +12.1% | 0.11% | +5.8% |
| Q4 2013 | $5,120,000 | +462.6% | 22,549 | +419.3% | 0.10% | +390.5% |
| Q3 2013 | $910,000 | +37.9% | 4,342 | +14.3% | 0.02% | +31.2% |
| Q2 2013 | $660,000 | – | 3,798 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |